These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2592981)

  • 1. Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicity.
    Elderson A; Gerritsen van der Hoop R; Haanstra W; Neijt JP; Gispen WH; Jennekens FG
    J Neurol Sci; 1989 Nov; 93(2-3):167-74. PubMed ID: 2592981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity.
    van den Bent MJ; van Putten WL; Hilkens PH; de Wit R; van der Burg ME
    Eur J Cancer; 2002 Feb; 38(3):387-91. PubMed ID: 11818204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer.
    van der Hoop RG; Vecht CJ; van der Burg ME; Elderson A; Boogerd W; Heimans JJ; Vries EP; van Houwelingen JC; Jennekens FG; Gispen WH
    N Engl J Med; 1990 Jan; 322(2):89-94. PubMed ID: 2152972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo.
    Hovestadt A; van der Burg ME; Verbiest HB; van Putten WL; Vecht CJ
    J Neurol; 1992 Mar; 239(3):143-6. PubMed ID: 1315383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibration perception thresholds in workers with long term exposure to lead.
    Chuang HY; Schwartz J; Tsai SY; Lee ML; Wang JD; Hu H
    Occup Environ Med; 2000 Sep; 57(9):588-94. PubMed ID: 10935939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
    Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
    Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy.
    Berger T; Malayeri R; Doppelbauer A; Krajnik G; Huber H; Auff E; Pirker R
    Eur J Cancer; 1997 Aug; 33(9):1393-9. PubMed ID: 9337680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.
    Hilkens PH; van der Burg ME; Moll JW; Planting AS; van Putten WL; Vecht CJ; van den Bent MJ
    Eur J Cancer; 1995; 31A(5):678-81. PubMed ID: 7640038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative sensory testing of cold and vibration perception during compression of median nerve at the wrist.
    Tsuboya H; Tani T; Ishida K; Ushida T; Taniguchi S; Kimura J
    Muscle Nerve; 2007 Apr; 35(4):458-64. PubMed ID: 17195168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTH/MSH like peptides in the treatment of cisplatin neuropathy.
    Gispen WH; Hamers FP; Vecht CJ; Jennekens FG; Neyt JP
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):179-83. PubMed ID: 1326318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
    Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory involvement in distal myopathy (Welander).
    Borg K; Borg J; Lindblom U
    J Neurol Sci; 1987 Sep; 80(2-3):323-32. PubMed ID: 3681336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal perception thresholds among young adults exposed to hand-transmitted vibration.
    Nilsson T; Burström L; Hagberg M; Lundström R
    Int Arch Occup Environ Health; 2008 Apr; 81(5):519-33. PubMed ID: 18180945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats.
    De Koning P; Neijt JP; Jennekens FG; Gispen WH
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):81-7. PubMed ID: 3590191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes over a workshift in aesthesiometric and vibrotactile perception thresholds of workers exposed to intermittent hand transmitted vibration from impact wrenches.
    Bovenzi M; Apostoli P; Alessandro G; Vanoni O
    Occup Environ Med; 1997 Aug; 54(8):577-87. PubMed ID: 9326161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
    Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
    PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of vibratory perception threshold using a new vibrometer TM-31A.
    Kamon N
    J Occup Med; 1994 Sep; 36(9):989-96. PubMed ID: 7823221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normative values of vibratory perception in 530 children, juveniles and adults aged 3-79 years.
    Hilz MJ; Axelrod FB; Hermann K; Haertl U; Duetsch M; Neundörfer B
    J Neurol Sci; 1998 Aug; 159(2):219-25. PubMed ID: 9741411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule.
    Hilkens PH; Planting AS; van der Burg ME; Moll JW; van Putten WL; Vecht CJ; van den Bent MJ
    Eur J Neurol; 1994 Sep; 1(1):45-50. PubMed ID: 24283428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative thermal perception thresholds relative to exposure to vibration.
    Nilsson T; Lundström R
    Occup Environ Med; 2001 Jul; 58(7):472-8. PubMed ID: 11404453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.